Why is Xi'an International Medical Investment Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 0%
- The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward
2
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of 15.72% and Operating profit at 9.63% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 0.33% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 15.72% and Operating profit at 9.63% over the last 5 years
4
Flat results in Mar 26
- NET SALES(9M) At CNY 3,009.61 MM has Grown at -11.28%
- CASH AND EQV(HY) Lowest at CNY 810.68 MM
- OPERATING PROFIT(Q) Lowest at CNY -44.15 MM
5
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -19.69%, its profits have risen by 10%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Hospital)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Xi'an International Medical Investment Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Xi'an International Medical Investment Co., Ltd.
-23.35%
-0.62
36.76%
China Shanghai Composite
19.22%
1.46
13.80%
Quality key factors
Factor
Value
Sales Growth (5y)
15.72%
EBIT Growth (5y)
9.63%
EBIT to Interest (avg)
-2.86
Debt to EBITDA (avg)
27.30
Net Debt to Equity (avg)
1.17
Sales to Capital Employed (avg)
0.56
Tax Ratio
5.61%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0.33%
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.70
EV to EBIT
-54.70
EV to EBITDA
42.04
EV to Capital Employed
1.80
EV to Sales
3.10
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-3.29%
ROE (Latest)
-11.05%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Movement
9What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 1,299.01 MM
RAW MATERIAL COST(Y)
Fallen by -1,928.57% (YoY
NET PROFIT(Q)
At CNY -46.3 MM has Grown at 53.06%
-5What is not working for the Company
NET SALES(9M)
At CNY 3,009.61 MM has Grown at -11.28%
CASH AND EQV(HY)
Lowest at CNY 810.68 MM
OPERATING PROFIT(Q)
Lowest at CNY -44.15 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -4.55 %
Here's what is working for Xi'an International Medical Investment Co., Ltd.
Operating Cash Flow
Highest at CNY 1,299.01 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Net Profit
At CNY -46.3 MM has Grown at 53.06%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
Raw Material Cost
Fallen by -1,928.57% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Xi'an International Medical Investment Co., Ltd.
Net Sales
At CNY 3,009.61 MM has Grown at -11.28%
Year on Year (YoY)MOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Operating Profit
Lowest at CNY -44.15 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at -4.55 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Cash and Eqv
Lowest at CNY 810.68 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents






